We have located links that may give you full text access.
Endoscopic radiofrequency ablation for palliative treatment of hilar cholangiocarcinoma.
VideoGIE 2021 April
BACKGROUND AND AIMS: Recent data support a role for endoscopic radiofrequency ablation (RFA) in unresectable cholangiocarcinoma by improving stent patency and overall survival.
METHODS: We describe 3 patients with inoperable cholangiocarcinoma with jaundice and cholestasis who were recommended palliative chemotherapy. They underwent endoscopic retrograde cholangiopancreatography with single-operator cholangioscope and intraductal RFA.
RESULTS: The procedures were performed without adverse events in all patients, with clinical and analytical improvement 1 month later.
CONCLUSIONS: RFA is a promising and safe palliative treatment in patients with unresectable cholangiocarcinoma.
METHODS: We describe 3 patients with inoperable cholangiocarcinoma with jaundice and cholestasis who were recommended palliative chemotherapy. They underwent endoscopic retrograde cholangiopancreatography with single-operator cholangioscope and intraductal RFA.
RESULTS: The procedures were performed without adverse events in all patients, with clinical and analytical improvement 1 month later.
CONCLUSIONS: RFA is a promising and safe palliative treatment in patients with unresectable cholangiocarcinoma.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app